LyphoMed Inc said Vestar Inc entered joint venture develop market liposome formulation selected drug .
Liposomes sphere subcellular size composed phospholipid , primary component living cell membrane .
During project 's first year , company jointly develop liposome formulation designated drug establish commercial production capacity well coordinate fund clinical study formulation .
Reuter & # 3 ; 